ArticleJournal of global infectious diseases

CSE-1034 versus Ceftriaxone: Efficacy and Safety Analysis from a Randomized, Open-labeled Phase III Study in Complicated Urinary Tract Infections.

Manu Chaudhary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.